A randomised, open label, active comparator trial assessing the effects of 26 weeks of liraglutide or sitagliptin on cardiovascular function in young obese adults with type 2 diabetes

Webb, DR, Htike, ZZ, Swarbrick, DJ et al. (13 more authors) (2020) A randomised, open label, active comparator trial assessing the effects of 26 weeks of liraglutide or sitagliptin on cardiovascular function in young obese adults with type 2 diabetes. Diabetes, Obesity and Metabolism. ISSN 1462-8902

Abstract

Metadata

Authors/Creators:
  • Webb, DR
  • Htike, ZZ
  • Swarbrick, DJ
  • Brady, EM
  • Gray, LJ
  • Biglands, J ORCID logo https://orcid.org/0000-0002-1161-5022
  • Gulsin, GS
  • Henson, J
  • Khunti, K
  • McCann, GP
  • Waller, HL
  • Webb, MA
  • Sargent, J
  • Yates, T
  • Zaccardi, F
  • Davies, MJ
Copyright, Publisher and Additional Information: © 2020 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Keywords: cardiac magnetic resonance; diastolic dysfunction; liraglutide; obesity; peak early diastolic strain rate; randomized controlled trial; sitagliptin; type 2 diabetes; young adults
Dates:
  • Accepted: 5 March 2020
  • Published (online): 10 March 2020
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Genetics, Health and Therapeutics (LIGHT) > Academic Unit of Medical Physics (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 12 Jun 2020 15:26
Last Modified: 12 Jun 2020 15:26
Status: Published online
Publisher: Wiley
Identification Number: https://doi.org/10.1111/dom.14023

Download

Share / Export

Statistics